OVID THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.34 USD | +7.74% |
|
+6.03% | +3.73% |
| 04-29 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
| 03-08 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Ovid Therapeutics Inc.
3e2487e97a.6TF63DoWgtLTQbutwK4U4zSE0uzzJXEabHYZHUq7YIU.qkQDpnJB8JngBYLFlO991n3P_53eRj1qIk8sLzjKKsqCdxSaC2H7oes59g~26c2e95ac384f6533d60d543f08ff775
Upcoming events on Ovid Therapeutics Inc.
Past events on Ovid Therapeutics Inc.
| 11/04/2024 14:30 | Needham Healthcare Conference |
| 08/03/2024 13:00 | Q4 2023 Earnings Release |
| 06/03/2024 15:30 | TD Cowen Health Care Conference |
| 13/02/2024 17:40 | Oppenheimer Healthcare Life Sciences Conference |
| 04/12/2023 17:00 | American Epilepsy Society Meeting - Poster #2.255 |
| 04/12/2023 17:00 | American Epilepsy Society Meeting - Poster #3.256 |
| 03/12/2023 17:00 | American Epilepsy Society Meeting - Poster #2.250 |
| 03/12/2023 17:00 | American Epilepsy Society Meeting - Poster #2.253 |
| 03/12/2023 17:00 | American Epilepsy Society Meeting - Poster #2.252 |
| 03/11/2023 12:00 | Q3 2023 Earnings Release |
| 12/10/2023 20:30 | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 02/10/2023 17:00 | Research & Development Day |
| 26/09/2023 14:55 | Cantor Global Healthcare Conference |
| 12/09/2023 15:30 | H.C. Wainwright Global Investment Conference |
| 06/09/2023 | Citi BioPharma Conference |
| 07/08/2023 14:30 | BTIG Virtual Biotechnology Conference |
| 04/08/2023 13:00 | Q2 2023 Earnings Release |
| 07/06/2023 | Annual General Meeting |
| 17/04/2023 16:00 | Needham Healthcare Conference |
| 15/03/2023 20:00 | Needham Virtual Neuroscience Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 12,6 11,1 13.87% | 208 208 -0% | 1,50 1,47 2.43% | 0,39 10,3 -96.19% | 12,8 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 124 140 -11.26% | -55,0 -54,3 -1.34% | -57,7 -22,0 -161.68% | -51,4 |
|
EBIT Million USD | Released Forecast Spread | -61,4 -61,8 0.56% | -81,4 -75,4 -8% | 149 139 6.93% | -55,5 -56,7 2.04% | -59,3 -43,8 -35.36% | -55,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -60,5 -61,3 1.38% | -81,0 -74,1 -9.31% | 124 139 -10.83% | -54,2 -55,7 2.72% | -52,3 -39,9 -31.21% | -51,4 |
|
Net income Million USD | Released Forecast Spread | -60,5 -61,2 1.17% | -81,0 -77,7 -4.3% | 123 138 -11.09% | -54,2 -55,5 2.47% | -52,3 -39,2 -33.48% | -51,4 |
|
EPS USD | Released Forecast Spread | -1,54 -1,65 6.38% | -1,39 -1,35 -3.12% | 1,76 1,93 -8.97% | -0,77 -0,79 2.07% | -0,74 -0,56 -33.25% | -0,70 |
| Announcement Date | 11/03/20 | 15/03/21 | 15/03/22 | 13/03/23 | 08/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 1,45 0,00 - | 0,00 0,00 - | 0,01 0,00 - | 0,05 0,00 - | 0,07 0,02 254.37% | 0,08 0,03 147.28% | 0,11 0,04 149.07% | 0,14 10,0 -98.59% | 0,05 | 0,06 | 0,06 | 16,9 | 0,05 |
|
EBITDA Million USD | Released Forecast Spread | -17,8 17,9 -199.62% | -12,4 | -12,7 | -13,0 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -11,6 -11,3 -3.39% | -14,3 -14,9 3.99% | -14,3 -17,5 18.11% | -12,8 -15,4 16.68% | -12,2 -13,8 11.75% | -14,9 -12,8 -16.62% | -14,2 -15,4 8.19% | -12,0 -14,2 15.16% | -18,2 -2,70 -573.6% | -16,8 | -17,3 | -18,1 | -1,62 | -17,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,3 -11,3 -133.94% | -16,1 -14,9 -7.92% | -14,6 -17,3 15.81% | -12,0 -15,4 22.26% | -11,5 -13,2 12.86% | -13,4 -12,3 -8.52% | -12,4 -14,4 13.99% | -11,3 -13,0 13.17% | -15,3 -6,20 -147.18% | -15,5 | -16,0 | -16,8 | -0,36 | -16,2 |
|
Net income Million USD | Released Forecast Spread | -26,0 -11,3 -130.84% | -16,1 -14,8 -8.65% | -14,6 -17,3 15.89% | -12,0 -15,4 22.26% | -11,5 -13,2 12.86% | -13,4 -12,3 -8.52% | -12,4 -14,4 13.99% | -11,3 -13,0 13.17% | -15,3 -6,20 -147.18% | -15,6 | -16,1 | -16,9 | -2,84 | -16,2 |
|
EPS USD | Released Forecast Spread | -0,38 -0,16 -132.66% | -0,23 -0,21 -7.81% | -0,21 -0,25 15.59% | -0,17 -0,21 20.64% | -0,16 -0,18 12.22% | -0,19 -0,17 -10.99% | -0,18 -0,21 13.58% | -0,16 -0,19 14.22% | -0,22 -0,03 -641.49% | -0,21 | -0,22 | -0,22 | -0,03 | -0,22 |
| Announcement Date | 15/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 13/03/23 | 05/05/23 | 04/08/23 | 03/11/23 | 08/03/24 | - | - | - | - | - |
More events
Past sector events for Ovid Therapeutics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OVID Stock
- Calendar Ovid Therapeutics Inc.
